Fecal transplantation for treatment of inflammatory bowel disease-Reference-Cited by-同舟云学术

Fecal transplantation for treatment of inflammatory bowel disease

Published:2023-04-25 Issue:4 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Imdad Aamer¹,Pandit Natasha G²,Zaman Muizz²,Minkoff Nathan Zev³,Tanner-Smith Emily E⁴,Gomez-Duarte Oscar G⁵,Acra Sari⁶,Nicholson Maribeth R⁶

Affiliation:

1. Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition; SUNY Upstate Medical University; Syracuse New York USA

2. Norton College of Medicine; SUNY Upstate Medical University; Syracuse New York USA

3. Pediatric Gastroenterology, Hepatology and Nutrition; Valley Children's Hospital; Madera CA USA

4. Counseling Psychology and Human Services; University of Oregon; Eugene Oregon USA

5. Division of Pediatric Infectious Diseases, Department of Pediatrics; University at Buffalo, State University of New York; Buffalo New York USA

6. Department of Pediatrics, D. Brent Polk Division of Gastroenterology, Hepatology and Nutrition; Vanderbilt University School of Medicine; Nashville Tennessee USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference203 articles.

1. Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis-results of a randomized controlled trial;Březina;Journal of Clinical Medicine,2021

2. Gut microbiome changes in patients with active left-sided ulcerative colitis after fecal microbiome transplantation and topical 5-aminosalicylic acid therapy;Schierová;Cells,2020

3. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial;Costello;JAMA,2019

4. Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study;Crothers;BMC Gastroenterology,2021

5. Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis (FMTUC) clinicaltrials.gov/ct2/show/NCT02390726

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the relationship between Faecalibacterium duncaniae and Escherichia coli in inflammatory bowel disease (IBD): Insights and implications;Computational and Structural Biotechnology Journal;2024-12

2. Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota;International Immunopharmacology;2024-10

3. Perspective: on the future of fecal microbiota transplantation;Frontiers in Microbiology;2024-09-09

4. High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model;Journal of Pharmacology and Experimental Therapeutics;2024-07-15

5. Fecal microbiota transplantation: current challenges and future landscapes;Clinical Microbiology Reviews;2024-06-13